Tortugas Neuroscience Raises $106 Million for Advancing Neurology Drug Development

Tortugas Neuroscience secures funding for Phase 2 clinical trials of lead drug candidates, totaling $106 million.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here